StockStory Favors Hims & Hers, Flags Two Healthcare Stocks
The publisher cited improving cash flow at Hims & Hers, while pointing to growth and efficiency concerns at Supernus and Elanco.
Makkler Newsroom · Oct 9, 03:39 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $31.25 (+16.7%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO